Maravai LifeSciences Holdings Inc’s recently made public that its General Counsel ORESHACK KURT unloaded Company’s shares for reported $0.13 million on Jan 31 ’25. In the deal valued at $5.03 per share,25,000 shares were sold. As a result of this transaction, ORESHACK KURT now holds 167,618 shares worth roughly $0.69 million.
Then, ORESHACK KURT bought 25,000 shares, generating $125,750 in total proceeds.
Before that, DeFord John A bought 17,500 shares. Maravai LifeSciences Holdings Inc shares valued at $100,625 were divested by the Director at a price of $5.75 per share. As a result of the transaction, DeFord John A now holds 70,046 shares, worth roughly $0.29 million.
Guggenheim initiated its Maravai LifeSciences Holdings Inc [MRVI] rating to a Neutral in a research note published recently. A number of analysts have revised their coverage, including Goldman’s analysts, who decreased its forecast for the stock in early December from “a Neutral” to “a Sell”. Wolfe Research began covering MRVI with “Peer perform” recommendation on November 14, 2024. William Blair revised its rating on November 08, 2024. It rated MRVI as “a Mkt perform” which previously was an “an Outperform”.
Price Performance Review of MRVI
On Friday, Maravai LifeSciences Holdings Inc [NASDAQ:MRVI] saw its stock jump 4.05% to $4.11. Over the last five days, the stock has lost -0.24%. Maravai LifeSciences Holdings Inc shares have fallen nearly -24.59% since the year began. Nevertheless, the stocks have fallen -22.74% over the past one year. While a 52-week high of $11.56 was reached on 01/08/25, a 52-week low of $3.94 was recorded on 02/21/25. SMA at 50 days reached $5.11, while 200 days put it at $7.36.
Levels Of Support And Resistance For MRVI Stock
The 24-hour chart illustrates a support level at 3.93, which if violated will result in even more drops to 3.74. On the upside, there is a resistance level at 4.30. A further resistance level may holdings at 4.48. The Relative Strength Index (RSI) on the 14-day chart is 35.37, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.35, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 84.62%. Stochastics %K at 6.52% indicates the stock is a buying.
The most recent change occurred on August 28, 2024 when Wells Fargo began covering the stock and recommended ‘”an Overweight”‘ rating along with a $10 price target.
